FMP
GlucoTrack, Inc.
GCTK
NASDAQ
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
0.358 USD
0.0019 (0.531%)
Historical Prices
From:
To:
About
ceo
Mr. Paul V. Goode Ph.D.
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.glucotrack.comexchange
NASDAQ
Description
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
CIK
0001506983
ISIN
US45824Q5071
CUSIP
45824Q507
Address
8 Ariel Sharon Street
Phone
972 8 675 7878
Country
IL
Employee
6
IPO Date
Apr 25, 2013
Financial Statement
Earnings
GCTK Financial Summary
CIK
0001506983
Exchange
NASDAQ
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
45824Q507
ISIN
US45824Q5071
Country
IL
Price
0.36
Beta
-0.3
Volume Avg.
3.91M
Market Cap
3.73M
Shares
-
52-Week
0.307-99
DCF
0.84
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.01
P/B
-
Website
https://www.glucotrack.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest GCTK News
Gordon Thompson
Feb 4, 2025
Glucotrack, Inc. Executes 20-for-1 Reverse Stock Split and A...
On February 4, 2025, Glucotrack, Inc. (NASDAQ:GCTK) executed a 20-for-1 reverse stock split. Glucotrack is a medical technology company focused on developing innovative solutions for diabetes management. The reverse stock split is a strategic move often used by companies to increase the per-share price by reducing the number of shares outstanding. In conjunction with the reverse stock split, Glucotrack announced a public offering of approximately 2.6 million shares at $1.15 per share. This offe...
GlobeNewsWire
Jun 10, 2024
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONF...
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the Sidoti Small Cap Investor Conference.
InvestorPlace
Apr 13, 2023
Why Is GlucoTrack (GCTK) Stock Down 36% Today?
GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it's planning for a firm commitment underwritten public offering.
PennyStocks
Apr 11, 2023
Spotting Winning Penny Stocks: 3 Top Tips
Can these tips help you make money with penny stocks in 2023? The post Spotting Winning Penny Stocks: 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
